Avadel Pharmaceuticals PLC (AVDL.OQ)
18 Apr 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|71||2014||Non-Executive Independent Chairman of the Board|
|68||2012||Chief Executive Officer, Director|
|53||2015||Senior Vice President, Chief Financial Officer|
|50||2018||Chief Operating Officer, Chief Commercial Officer, Executive Vice President|
|42||2013||Senior Vice President, General Counsel, Corporate Secretary|
- BRIEF-Avadel Pharmaceuticals Announces Promotion Of Gregory Divis To COO
- BRIEF-Avadel Pharmaceuticals Reports Q4 Adjusted Loss Per Share $0.28
- BRIEF-Avadel Pharmaceuticals Announces Pricing Of $125 Mln 4.50 Pct Exchangeable Senior Notes
- BRIEF-Avadel Pharmaceuticals Announces Proposed Exchangeable Senior Notes Offering
- BRIEF-Avadel Pharma Receives Orphan Drug Designation From FDA For FT 218